According to Rani Therapeutics's latest financial reports the company's current EPS (TTM) is -1,30ย โฌ. In 2022 the company made an earnings per share (EPS) of -1,21ย โฌ a decrease over its 2021 EPS that were of -0,41ย โฌ.